According to a new market research report " Cell Lysis/Cell Fractionation Market by Product (Consumables (Reagents, Enzymes, Detergent), Instruments (Sonicator, Homogenizer)), Type of Cell (Microbial, Mammalian), End User (Research Laboratories, Biopharmaceutical & Biotechnology Companies) - Global Forecasts to 2021", published by MarketsandMarkets.
- Advertising -
The global Cell Lysis Market is expected to reach USD 3.84 Billion by 2021 from USD 2.35 Billion in 2016 at a CAGR of 10.3% from 2016 to 2021.
Browse 84 market data Tables and 41 Figures spread through 135 Pages and in-depth TOC on"Cell Lysis/Cell Fractionation Market"
The major factor driving the growth of this market are increasing government funding for research, high prevalence of diseases, expanding biotechnology and biopharmaceutical industries, and a growing focus on personalized medicine
The report segments this market based on product, type of cell, end-users, and regions.
Among the various product, the consumables segment is expected to account for the largest share of the market.
- Advertising -
The consumables market includes reagents and kits, beads, and disposables. Reagents and kits are further classified into enzymes, detergent solutions, and other reagents and kits.
Enzymes segment is projected to grow at the highest CAGR from 2016 to 2021. The high growth of enzymes segment can be attributed to the increased investments for cell-based research.
Download PDF Brochure: www.marketsandmarkets.com/pdfdownload.asp?id=260138321
On the basis of type of cell, the Cell Lysis Market is segmented into mammalian cells, microbial cells, and other cells. The mammalian cells segment is expected to account for the largest share of the global Cell Lysis Market in 2016.
Rising aging population and increasing need for the development of new cell therapies are the key factors propelling the growth of this market.
End-users, included in the Cell Lysis Market are research laboratories and institutes, biopharmaceutical and biotechnology companies, and others. The research laboratories and institutes segment are expected to account for the largest share of the global Cell Lysis Market in 2016.
High incidence of diseases and research investments in life sciences is driving the growth of this market.
Based on regions, the global Cell Lysis/Cell Fractionation Market is segmented into North America, Europe, Asia, and the Rest of the World (RoW). North America is expected to account for the largest share of the market during the forecast period.
Growth in this regional segment is driven by factors such as an increase in aging population, and increasing government funding in North America.
Talk To Our Research Experts: www.marketsandmarkets.com/speaktoa…m_campaign=PaidPR
Key players in the Cell Lysis Market include Beckman Coulter, Inc. (U.S.), Becton, Dickinson and Company (U.S.), Bio-Rad Laboratories, Inc.
(U.S.), Cell Signaling Technology, Inc. (U.S.), F. Hoffman-La Roche AG (Switzerland), Merck KGaA (Germany), Miltenyi Biotec (Germany), QIAGEN N.V.
(Netherlands), Qsonica, LLC. (U.S.), and Thermo Fisher Scientific Inc. (U.S.).
Category: Market Research Publishers and RetailersCompany about: MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions. Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth ...